Stroke Is Different in Systemic Lupus Erythematosus: Implications for Survival and Functionality

REFERENCES

1. 1.↵
   1. Holmqvist M,
   2. Simard JF,
   3. Asplund K,
   4. Arkema EV

   . Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies. RMD Open 2015;1:e000168.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Arkema EV,
   2. Svenungsson E,
   3. Von Euler M,
   4. Sjöwall C,
   5. Simard JF

   . Stroke in systemic lupus erythematosus: a Swedish population-based cohort study. Ann Rheum Dis 2017;76:1544-9.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Ward MM

   . Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus. Arthritis Rheum 2004;50:3170-6.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Krishnan E

   . Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med 2005;118:1415.

   OpenUrlPubMed
5. 5.↵
   1. Rossides M,
   2. Simard JF,
   3. Svenungsson E,
   4. Von Euler M,
   5. Arkema EV

   . Mortality and functionality after stroke in patients with systemic lupus erythematosus. J Rheumatol 2017;44:1590-6.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Tsoi LK,
   2. Mok CC,
   3. Man BL,
   4. Fu YP

   . Imaging pattern and outcome of stroke in patients with systemic lupus erythematosus: a case-control study. J Rheumatol 2021;48:533-40.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. van Swieten JC,
   2. Koudstaal PJ,
   3. Visser MC,
   4. Schouten HJ,
   5. van Gijn J

   . Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Wang Y,
   2. Zhou L,
   3. Guo J,
   4. Wang Y,
   5. Yang Y,
   6. Peng Q, et al.

   Secular trends of stroke incidence and mortality in China, 1990 to 2016: The Global Burden of Disease Study 2016. J Stroke Cerebrovasc Dis 2020;29:104959.

   OpenUrl
9. 9.↵
   1. Zhang LF,
   2. Yang J,
   3. Hong Z,
   4. Yuan GG,
   5. Zhou BF,
   6. Zhao LC, et al; Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology

   . Proportion of different subtypes of stroke in China. Stroke 2003;34:2091-6.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Ma P,
    2. Zhou J,
    3. Wang S,
    4. Li T,
    5. Fan X,
    6. Fan J, et al.

    Differences of hemorrhagic and ischemic strokes in age spectra and responses to climatic thermal conditions. Sci Total Environ 2018;644:1573-9.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Schoenfeld SR,
    2. Kasturi S,
    3. Costenbader KH

    . The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Semin Arthritis Rheum 2013;43:77-95.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Kaichi Y,
    2. Kakeda S,
    3. Moriya J,
    4. Ohnari N,
    5. Saito K,
    6. Tanaka Y, et al.

    Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome. Am J Neuroradiol 2014;35:100-5.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Valdés-Ferrer SI,
    2. Vega F,
    3. Cantú-Brito C,
    4. Ceballos-Ceballos J,
    5. Estañol B,
    6. García-Ramos G, et al.

    Cerebral Changes in SLE with or without antiphospholipid syndrome. A case-control MRI study. J Neuroimaging 2008;18:62-5.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Yong SW,
    2. Bang OY,
    3. Lee PH,
    4. Li WY

    . Internal and cortical border-zone infarction: clinical and diffusion-weighted imaging features. Stroke 2006;37:841-6.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Sibbitt WL Jr,
    2. Brooks WM,
    3. Kornfeld M,
    4. Hart BL,
    5. Bankhurst AD,
    6. Roldan CA

    . Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 2010;40:32-52.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Csépány T,
    2. Bereczki D,
    3. Kollár J,
    4. Sikula J,
    5. Kiss E,
    6. Csiba L

    . MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension. J Neurol 2003;250:1348-54.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Pamfil C,
    2. Fanouriakis A,
    3. Damian L,
    4. Rinzis M,
    5. Sidiropoulos P,
    6. Tsivgoulis G, et al.

    EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres. Rheumatology 2015;54:1270-8.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Govoni M,
    2. Bombardieri S,
    3. Bortoluzzi A,
    4. Caniatti L,
    5. Casu C,
    6. Conti F, et al; Italian Society of Rheumatology

    . Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology 2012;51:157–68.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Tektonidou MG,
    2. Laskari K,
    3. Panagiotakos DB,
    4. Moutsopoulos HM

    . Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Care Res 2008;61:29-36.

    OpenUrl
20. 20.↵
    1. Kernan WN,
    2. Ovbiagele B,
    3. Black HR,
    4. Bravata DM,
    5. Chimowitz MI,
    6. Ezekowitz MD, et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease

    . Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160-236.

    OpenUrlAbstract/FREE Full Text